Acadia Pharmaceuticals to Present at the Canaccord Genuity 41st Annual Growth Conference on August 12, 2021

Rhea-AI Summary

Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) announced its participation in the Canaccord Genuity 41^st Annual Growth Conference on August 12, 2021, at 3:00 p.m. Eastern Time. The event will be held virtually, with a live webcast available on Acadia's website, www.acadia-pharm.com. An archived recording will be accessible until September 12, 2021. Acadia specializes in neuroscience, focusing on therapies for Parkinson's disease psychosis and exploring new treatments for dementia-related psychosis and other CNS disorders.

Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will present at the Canaccord Genuity 41^st Annual Growth Conference on Thursday, August 12, 2021, at 3:00 p.m. Eastern Time.

The conference will be held virtually. A live webcast of Acadia’s presentation will be accessible on the company’s website, www.acadia-pharm.com, under the investors section and an archived recording will be available on the website through September 12, 2021.

About Acadia Pharmaceuticals

Acadia is trailblazing breakthroughs in neuroscience to elevate life. For more than 25 years we have been working at the forefront of healthcare to bring vital solutions to people who need them most. We developed and commercialized the first and only approved therapy for hallucinations and delusions associated with Parkinson’s disease psychosis. Our late-stage development efforts are focused on dementia-related psychosis, negative symptoms of schizophrenia and Rett syndrome, and in early-stage clinical research we are exploring novel approaches to pain management, and cognition and neuropsychiatric symptoms in central nervous system disorders. For more information, visit us at www.acadia-pharm.com and follow us on LinkedIn and Twitter.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210805005973/en/

FAQ

When is Acadia Pharmaceuticals presenting at the Canaccord Genuity 41st Annual Growth Conference?

Acadia Pharmaceuticals will present on August 12, 2021, at 3:00 p.m. Eastern Time.

Where can I watch Acadia Pharmaceuticals' presentation at the conference?

The presentation can be watched live on Acadia's website at www.acadia-pharm.com.

How long will the recorded presentation from Acadia Pharmaceuticals be available?

The archived recording will be available until September 12, 2021.

What areas is Acadia Pharmaceuticals focusing on in its drug development?

Acadia is focused on therapies for dementia-related psychosis, schizophrenia, Rett syndrome, and pain management.

What is the stock symbol for Acadia Pharmaceuticals?

The stock symbol for Acadia Pharmaceuticals is ACAD.